Certain Skin Rejuvenation Resurfacing Devices, Components Thereof, and Products Containing the Same; Institution of Investigation, 20712-20713 [2021-08159]
Download as PDF
20712
Federal Register / Vol. 86, No. 75 / Wednesday, April 21, 2021 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
The Commission subsequently issued
its final determinations that an industry
in the United States was materially
injured by reason of imports of PC
strand from Argentina, Colombia, Egypt,
Netherlands, Saudi Arabia, Taiwan,
Turkey, and the United Arab Emirates
provided for in subheading 7312.10.30
of the Harmonized Tariff Schedule of
the United States (‘‘HTSUS’’) that have
been found by the Commerce to be sold
in the United States at LTFV and
subsidized by the government of
Turkey. Commerce has issued final
affirmative antidumping duty
determinations with respect to PC
strand from Indonesia,3 Italy,4
Malaysia,5 South Africa,6 Spain,7
Tunisia,8 and Ukraine.9 Accordingly,
the Commission currently is issuing a
supplemental schedule for its
antidumping duty investigations on
imports of PC strand from Indonesia,
Italy, Malaysia, South Africa, Spain,
Tunisia, and Ukraine. This
supplemental schedule is as follows: the
deadline for filing supplemental party
comments on Commerce’s final
antidumping duty determinations is
April 19, 2021. Supplemental party
comments may address only
Commerce’s final antidumping duty
determinations regarding imports of PC
strand from Indonesia, Italy, Malaysia,
South Africa, Spain, Tunisia, and
Ukraine. These supplemental final
comments may not contain new factual
information and may not exceed five (5)
pages in length. The supplemental staff
report in the final phase of these
investigations regarding subject imports
from Indonesia, Italy, Malaysia, South
3 Prestressed Concrete Steel Wire Strand from
Indonesia: Final Affirmative Determination of Sales
at Less Than Fair Value, and Final Affirmative
Determination of Critical Circumstances, In Part, 86
FR 18495, April 9, 2021.
4 Prestressed Concrete Steel Wire Strand from
Italy: Final Affirmative Determination of Sales at
Less Than Fair Value, and Final Negative
Determination of Critical Circumstances, 86 FR
18505, April 9, 2021.
5 Prestressed Concrete Steel Wire Strand from
Malaysia: Final Affirmative Determination of Sales
at Less Than Fair Value, 86 FR 18502, April 9,
2021.
6 Prestressed Concrete Steel Wire Strand from
South Africa: Final Affirmative Determination of
Sales at Less Than Fair Value, 86 FR 18497, April
9, 2021.
7 Prestressed Concrete Steel Wire Strand from
Spain: Final Affirmative Determination of Sales at
Less Than Fair Value, and Final Negative
Determination of Critical Circumstances, 86 FR
18512, April 9, 2021.
8 Prestressed Concrete Steel Wire Strand from
Tunisia: Final Affirmative Determination of Sales at
Less Than Fair Value, 86 FR 18508, April 9, 2021.
9 Prestressed Concrete Steel Wire Strand from
Ukraine: Final Affirmative Determination of Sales
at Less Than Fair Value, and Final Negative
Determination of Critical Circumstances, 86 FR
18498, April 9, 2021.
VerDate Sep<11>2014
18:12 Apr 20, 2021
Jkt 253001
Africa, Spain, Tunisia, and Ukraine will
be placed in the nonpublic record on
May 4, 2021; and a public version will
be issued thereafter.
For further information concerning
these investigations see the
Commission’s notice cited above and
the Commission’s Rules of Practice and
Procedure, part 201, subparts A and B
(19 CFR part 201), and part 207,
subparts A and C (19 CFR part 207).
Additional written submissions to the
Commission, including requests
pursuant to section 201.12 of the
Commission’s rules, shall not be
accepted unless good cause is shown for
accepting such submissions, or unless
the submission is pursuant to a specific
request by a Commissioner or
Commission staff.
In accordance with sections 201.16(c)
and 207.3 of the Commission’s rules,
each document filed by a party to the
investigations must be served on all
other parties to the investigations (as
identified by either the public or BPI
service list), and a certificate of service
must be timely filed. The Secretary will
not accept a document for filing without
a certificate of service.
Authority: : These investigations are being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to section 207.21 of the
Commission’s rules.
By order of the Commission.
Issued Date: April 15, 2021.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2021–08178 Filed 4–20–21; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–1262]
Certain Skin Rejuvenation Resurfacing
Devices, Components Thereof, and
Products Containing the Same;
Institution of Investigation
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that a
complaint was filed with the U.S.
International Trade Commission on
March 16, 2021, under section 337 of
the Tariff Act of 1930, as amended, on
behalf of InMode Ltd. of Israel and
Invasix Inc. d/b/a InMode of Lake
Forest, California. Supplements to the
complaint were filed on April 1 and
April 5, 2021. The complaint alleges
violations of section 337 based upon the
importation into the United States, the
SUMMARY:
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
sale for importation, and the sale within
the United States after importation of
certain skin rejuvenation resurfacing
devices, components thereof, and
products containing the same by reason
of infringement of a claim of U.S. Patent
No. 10,799,285 (‘‘the ’285 patent’’). The
complaint further alleges that an
industry in the United States exists as
required by the applicable Federal
Statute. The complainants request that
the Commission institute an
investigation and, after the
investigation, issue a limited exclusion
order and cease and desist orders.
ADDRESSES: The complaint, except for
any confidential information contained
therein, may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov. For help
accessing EDIS, please email
EDIS3Help@usitc.gov. Hearing impaired
individuals are advised that information
on this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810. Persons
with mobility impairments who will
need special assistance in gaining access
to the Commission should contact the
Office of the Secretary at (202) 205–
2000. General information concerning
the Commission may also be obtained
by accessing its internet server at
https://www.usitc.gov.
FOR FURTHER INFORMATION CONTACT:
Katherine Hiner, Office of the Secretary,
Docket Services Division, U.S.
International Trade Commission,
telephone (202) 205–1802.
SUPPLEMENTARY INFORMATION:
Authority:
The authority for institution of this
investigation is contained in section 337
of the Tariff Act of 1930, as amended,
19 U.S.C. 1337, and in section 210.10 of
the Commission’s Rules of Practice and
Procedure, 19 CFR 210.10 (2020).
Scope of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
April 15, 2021, ordered that—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of certain products
identified in paragraph (2) by reason of
infringement of claim 1 of the ’285
patent; and whether an industry in the
United States exists as required by
subsection (a)(2) of section 337;
(2) Pursuant to section 210.10(b)(1) of
the Commission’s Rules of Practice and
Procedure, 19 CFR 210.10(b)(1), the
E:\FR\FM\21APN1.SGM
21APN1
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 75 / Wednesday, April 21, 2021 / Notices
plain language description of the
accused products or category of accused
products, which defines the scope of the
investigation, is ‘‘skin resurfacing
devices, punctile resurfacing systems,
radio-frequency microneedling systems,
and components of each’’;
(3) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainants are:
InMode Ltd., Tavor Building Shaar
Yokneam, P.O. Box 533, Yokneam
2069206, Israel
Invasix Inc. d/b/a InMode, 20996 Bake
Parkway, Suite 106, Lake Forest, CA
92630
(b) The respondents are the following
entities alleged to be in violation of
section 337, and the parties upon which
the complaint is to be served:
ILOODA Co., Ltd., 120 Jangan-ro
458beon-gil, Jangan-gu Suwon, 16200,
Republic of Korea
Cutera, Inc., 3240 Bayshore Boulevard,
Brisbane, CA 94005
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
The Office of Unfair Import
Investigations is not a party to this
investigation.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), as
amended in 85 FR 15798 (March 19,
2020), such responses will be
considered by the Commission if
received not later than 20 days after the
date of service by the complainants of
the complaint and the notice of
investigation. Extensions of time for
submitting responses to the complaint
and the notice of investigation will not
be granted unless good cause therefor is
shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
VerDate Sep<11>2014
18:12 Apr 20, 2021
Jkt 253001
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: April 15, 2021.
Lisa Barton
Secretary to the Commission.
20713
other activity for this drug code is
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–08165 Filed 4–20–21; 8:45 am]
BILLING CODE P
[FR Doc. 2021–08159 Filed 4–20–21; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 7020–02–P
Drug Enforcement Administration
[Docket No. 17–11]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–823]
Bulk Manufacturer of Controlled
Substances Application: Research
Triangle Institute
Drug Enforcement
Administration, Department of Justice.
ACTION: Notice of application.
AGENCY:
Research Triangle Institute,
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before June 21, 2021. Such persons
may also file a written request for a
hearing on the application on or before
June 21, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on March 18, 2021,
Research Triangle Institute, 3040 East
Cornwallis Road, Hermann Building,
Room 106, Research Triangle Park,
North Carolina 27709, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
Tetrahydrocannabinols ....
I
Schedule
7370
II
The company plans to bulk
manufacture the listed controlled
substance synthetically only for
distribution to its customers for research
and analytical reference standards. No
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Mark A. Wimbley, M.D.; Decision and
Order
I. Procedural History
On October 20, 2016, a former
Assistant Administrator, Diversion
Control Division, Drug Enforcement
Administration (hereinafter, DEA or
Government), issued an Order to Show
Cause (hereinafter, OSC) to Mark A.
Wimbley, M.D. (hereinafter,
Respondent), of Costa Mesa, California.
Administrative Law Judge (hereinafter,
ALJ) Exhibit (hereinafter, ALJX) 1,
(OSC) at 1. The OSC proposed the
revocation of and denial of any pending
application to modify or renew
Respondent’s Certificate of Registration
No. BW5359004 pursuant to 21 U.S.C.
823(f) and 824(a)(4) for the reason that
‘‘[his] continued registration is
inconsistent with the public interest, as
that term is defined in 21 U.S.C. 823(f).’’
Id.
The OSC alleged that Respondent
issued prescriptions for controlled
substances to four 1 individuals outside
the usual course of the professional
practice in violation of 21 CFR
1306.04(a) and in violation of California
law and the minimum standards of
medical practice in California. Id. at 2–
8. Specifically, the OSC alleged that
Respondent ‘‘issued these orders for
controlled substances without meeting
the minimal medical standards required
under California law, including those
listed in the ‘Guide to the Laws
Governing the Practice of Medicine by
Physicians and Surgeons,’ Medical
Board of California, 7th Ed. 2013.’’ Id.
at 7. Additionally, the OSC alleged that
for the four listed patients, Respondent
failed to do one or more of the
following:
perform a physical examination; take
appropriate medical history; assess pain,
physical and psychological function; make
an assessment of any underlying or
coexisting diseases or conditions; confirm the
patient was taking previously prescribed
1 The Government withdrew allegations related to
one of the patients in its Supplemental Prehearing
Statement, so this matter is limited to three
patients. ALJX 7, 7–8.
E:\FR\FM\21APN1.SGM
21APN1
Agencies
[Federal Register Volume 86, Number 75 (Wednesday, April 21, 2021)]
[Notices]
[Pages 20712-20713]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08159]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1262]
Certain Skin Rejuvenation Resurfacing Devices, Components
Thereof, and Products Containing the Same; Institution of Investigation
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that a complaint was filed with the
U.S. International Trade Commission on March 16, 2021, under section
337 of the Tariff Act of 1930, as amended, on behalf of InMode Ltd. of
Israel and Invasix Inc. d/b/a InMode of Lake Forest, California.
Supplements to the complaint were filed on April 1 and April 5, 2021.
The complaint alleges violations of section 337 based upon the
importation into the United States, the sale for importation, and the
sale within the United States after importation of certain skin
rejuvenation resurfacing devices, components thereof, and products
containing the same by reason of infringement of a claim of U.S. Patent
No. 10,799,285 (``the '285 patent''). The complaint further alleges
that an industry in the United States exists as required by the
applicable Federal Statute. The complainants request that the
Commission institute an investigation and, after the investigation,
issue a limited exclusion order and cease and desist orders.
ADDRESSES: The complaint, except for any confidential information
contained therein, may be viewed on the Commission's electronic docket
(EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email
[email protected]. Hearing impaired individuals are advised that
information on this matter can be obtained by contacting the
Commission's TDD terminal on (202) 205-1810. Persons with mobility
impairments who will need special assistance in gaining access to the
Commission should contact the Office of the Secretary at (202) 205-
2000. General information concerning the Commission may also be
obtained by accessing its internet server at https://www.usitc.gov.
FOR FURTHER INFORMATION CONTACT: Katherine Hiner, Office of the
Secretary, Docket Services Division, U.S. International Trade
Commission, telephone (202) 205-1802.
Supplementary Information:
Authority:
The authority for institution of this investigation is contained
in section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337,
and in section 210.10 of the Commission's Rules of Practice and
Procedure, 19 CFR 210.10 (2020).
Scope of Investigation: Having considered the complaint, the U.S.
International Trade Commission, on April 15, 2021, ordered that--
(1) Pursuant to subsection (b) of section 337 of the Tariff Act of
1930, as amended, an investigation be instituted to determine whether
there is a violation of subsection (a)(1)(B) of section 337 in the
importation into the United States, the sale for importation, or the
sale within the United States after importation of certain products
identified in paragraph (2) by reason of infringement of claim 1 of the
'285 patent; and whether an industry in the United States exists as
required by subsection (a)(2) of section 337;
(2) Pursuant to section 210.10(b)(1) of the Commission's Rules of
Practice and Procedure, 19 CFR 210.10(b)(1), the
[[Page 20713]]
plain language description of the accused products or category of
accused products, which defines the scope of the investigation, is
``skin resurfacing devices, punctile resurfacing systems, radio-
frequency microneedling systems, and components of each'';
(3) For the purpose of the investigation so instituted, the
following are hereby named as parties upon which this notice of
investigation shall be served:
(a) The complainants are:
InMode Ltd., Tavor Building Shaar Yokneam, P.O. Box 533, Yokneam
2069206, Israel
Invasix Inc. d/b/a InMode, 20996 Bake Parkway, Suite 106, Lake Forest,
CA 92630
(b) The respondents are the following entities alleged to be in
violation of section 337, and the parties upon which the complaint is
to be served:
ILOODA Co., Ltd., 120 Jangan-ro 458beon-gil, Jangan-gu Suwon, 16200,
Republic of Korea
Cutera, Inc., 3240 Bayshore Boulevard, Brisbane, CA 94005
(4) For the investigation so instituted, the Chief Administrative
Law Judge, U.S. International Trade Commission, shall designate the
presiding Administrative Law Judge.
The Office of Unfair Import Investigations is not a party to this
investigation.
Responses to the complaint and the notice of investigation must be
submitted by the named respondents in accordance with section 210.13 of
the Commission's Rules of Practice and Procedure, 19 CFR 210.13.
Pursuant to 19 CFR 201.16(e) and 210.13(a), as amended in 85 FR 15798
(March 19, 2020), such responses will be considered by the Commission
if received not later than 20 days after the date of service by the
complainants of the complaint and the notice of investigation.
Extensions of time for submitting responses to the complaint and the
notice of investigation will not be granted unless good cause therefor
is shown.
Failure of a respondent to file a timely response to each
allegation in the complaint and in this notice may be deemed to
constitute a waiver of the right to appear and contest the allegations
of the complaint and this notice, and to authorize the administrative
law judge and the Commission, without further notice to the respondent,
to find the facts to be as alleged in the complaint and this notice and
to enter an initial determination and a final determination containing
such findings, and may result in the issuance of an exclusion order or
a cease and desist order or both directed against the respondent.
By order of the Commission.
Issued: April 15, 2021.
Lisa Barton
Secretary to the Commission.
[FR Doc. 2021-08159 Filed 4-20-21; 8:45 am]
BILLING CODE 7020-02-P